Non-myeloablative allogenic peripheral blood stem cell transplantation in a patient with refractory osteosarcoma

Pediatric Transplantation

Volumn 9, Issue 3, 2005, Pages 342-345

  Kounami, Shinji ^a   Nakayama, Keiko ^a   Yoshiyama, Megumi ^a   Yoshimasu, Tetsu ^a   Aoyagi, Noriyuki ^a   Yoshikawa, Norishige ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Graft vs. tumor effect; Non myeloablative hematopoietic stem cell transplantation; Osteosarcoma

Indexed keywords

CYCLOSPORIN A; HLA ANTIGEN;

ADOLESCENT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS OSTEOSARCOMA EFFECT; HUMAN; MALE; OSTEOSARCOMA; PROGNOSIS; RELAPSE; REMISSION; TUMOR GROWTH;

ADOLESCENT; BONE NEOPLASMS; CHRONIC DISEASE; DISEASE PROGRESSION; FATAL OUTCOME; GRAFT VS HOST DISEASE; HUMANS; LUNG NEOPLASMS; MALE; OSTEOSARCOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TREATMENT FAILURE;

EID: 20344390793     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00290.x     Document Type: Article

References (15)

1. JAFFE N, FARBER S, TRAGGIS D, et al. Favorable response of metastatic osteogenic sarcoma to pulse high dose methotrexate with citrovorum rescue and radiation therapy. Cancer 1973: 31: 1367-1373.
2. BACCI G, LARI S. Current treatment of high grade osteosarcoma of the extremity: review. J Chemother 2001: 13: 235-243.
3. TABONE MD, KALIFA C, RODARY C, RAQUIN M, VALTEAUCOUANET D, LEMERLE J. Osteosarcoma recurrence in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol 1994: 12: 2614-2620.
4. FERGUSON WS, GOORIN AM. Current treatment of osteosarcoma. Cancer Invest 2001: 19: 292-315.
5. SAUERBREY A, BIELACK S, KEMPF-BIELACK B, ZOUBEK A, PAULUSSEN M, ZINTL F. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma. Bone Marrow Transplant 2001: 27: 933-937.
6. FAGIOLI F, AGLIETTA M, TIENGHI A, et al. High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian Sarcoma Group Study. J Clin Oncol 2002: 20: 2150-2156.
7. GULBAHCE HE, MANIVEL JC, JESSURUN J. Pulmonary cytolytic thrombi: a previously unrecognized complication of bone marrow transplantation. Am J Surg Pathol 2000: 24: 1147-1152.
8. BARRETT J, CHILDS R. Non-myeloablative stem cell transplants. Br J Haematol 2000: 111: 6-17.
9. STORB R. Allogenic hematopoietic stem cell transplantation-yesterday, today and tomorrow. Exp Hematol 2003: 31: 1-10.
10. CHILDS R, CHERNOFF A, CONTENTIN N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogenic peripheral-blood stem-cell transplantation. N Engl J Med 2000: 343: 750-758.
11. BREGNI M, DODERO A, PECCATORI J, et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood 2002: 99: 4234.
12. PEDRAZZOLI P, DAPRADA GA, GIORGIANI G, et al. Allogenic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies. Cancer 2002: 94: 2409-2415.
13. CASTAGNA L, BERTUZZI A, NOZZA A, et al. Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas. Bone Marrow Transplant 2002: 30: 207-214.
14. CARELLA AM, CAVALIERE M, LERMA E, et al. Autograft followed by nonmyeloablative immunosuppressive chemotherapy and allogenic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma. J Clin Oncol 2000: 18: 3918-3924.
15. PECCATORI J, BREGNI M. Allogenic non-myeloablative peripheral-blood stem cell transplantation in solid tumors. Suppl Tumori 2002: 1: S32.